ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2011

Aug 8, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2011-08-05

Reporting Person: Cormack Scott Daniel (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-08-05	Common Stock	M	5000	$4.1051	Acquired	18067	Direct
2011-08-05	Common Stock	G	5000	$0.00	Disposed	13067	Direct
2011-08-05	Common Stock	G	5000	$0.00	Acquired	49340	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-05	Stock Options	$4.1051	M	5000	Disposed	2012-08-08	Common (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	8092	Indirect

Footnotes

F1: Scott Cormack and his spouse are the trustees and beneficiaries of the Trycor Investment Trust No. 1